Scholars International Journal of Obstetrics and Gynecology (SIJOG)
Volume-9 | Issue-08 | 206-212
Original Research Article
Comparison of Glycemic Control between Regular Aspart Insulin and Regular Human Insulin in Gestational Diabetes Mellitus
Mst. Faima Khatun, Khadiza Akter, Umme Sakia Kauser, Soma Bagche, Moumita Ghosh Rupa, Ashrafi Yasmin, Shahrina Alam
Published : Aug. 31, 2026
Abstract
Background: Insulin therapy is required in gestational diabetes mellitus (GDM) when glycaemic targets are not achieved
through lifestyle modification and rapid acting insulin analogues such as regular aspart insulin have been developed to
provide more physiological postprandial and fasting glucose control than regular human insulin. This study aimed to
compare glycemic control, including fasting, postprandial and glycated haemoglobin parameters, between regular aspart
insulin and regular human insulin in women with gestational diabetes mellitus. Methods: This randomized controlled
trial was conducted in the outpatient department of Obstetrics and Gynaecology, BIRDEM General Hospital, Dhaka,
from October 2023 to January 2025, among 102 pregnant women with GDM diagnosed after 24 weeks of gestation.
Participants were randomly allocated to regular aspart insulin (Group I, n=54) or regular human insulin (Group II, n=48);
49 and 46 women respectively completed follow up at 28, 32 and 36 weeks of gestation and after delivery. Fasting blood
sugar, postprandial glucose two hours after breakfast, lunch and dinner and HbA1c were compared using SPSS version
26, with p<0.05 considered significant. Results: Mean age of participants was 29.2 ± 4.6 years and 63.16% were obese
before pregnancy. Fasting glucose was significantly lower in Group I at every assessment point (p<0.0001). Postprandial
glucose values were also significantly higher in Group II at 28 weeks (p<0.05 for all three postprandial readings), but
these differences attenuated by 32 and 36 weeks and after delivery. HbA1c was comparable between groups at 28 weeks
(6.1 ± 1.0 versus 6.4 ± 1.4, p=0.327) and 36 weeks (5.8 ± 1.0 versus 5.9 ± 1.4, p=0.697). Conclusion: Regular aspart
insulin provided superior fasting glycaemic control throughout pregnancy and more favourable early postprandial control
than regular human insulin, while overall glycated haemoglobin remained comparable, supporting its use as an effective
glycaemic management option in gestational diabetes mellitus.